Chemoinformaics analysis of 14-Oxy-alpha-muurolene
| Molecular Weight | 450.66 | nRot | 5 |
| Heavy Atom Molecular Weight | 404.292 | nRig | 24 |
| Exact Molecular Weight | 450.335 | nRing | 4 |
| Solubility: LogS | -2.374 | nHRing | 0 |
| Solubility: LogP | 6.547 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 78 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 32 | No. of Aromatic Carbocycles | 0 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 4 |
| No. of Hydrogen atom | 46 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 27 | No. of Saturated Rings | 4 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 0 |
| nHA | 5 | APOL | 79.7725 |
| nHD | 4 | BPOL | 47.0155 |
| QED | 0.522 |
| Synth | 3.231 |
| Natural Product Likeliness | 2.48 |
| NR-PPAR-gamma | 0.931 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.766 |
| Pgp-sub | 0.002 |
| HIA | 0.073 |
| CACO-2 | -4.744 |
| MDCK | 0.0000169 |
| BBB | 0.003 |
| PPB | 0.959011 |
| VDSS | 0.48 |
| FU | 0.0667357 |
| CYP1A2-inh | 0.511 |
| CYP1A2-sub | 0.391 |
| CYP2c19-inh | 0.937 |
| CYP2c19-sub | 0.067 |
| CYP2c9-inh | 0.914 |
| CYP2c9-sub | 0.936 |
| CYP2d6-inh | 0.478 |
| CYP2d6-sub | 0.457 |
| CYP3a4-inh | 0.37 |
| CYP3a4-sub | 0.145 |
| CL | 2.38 |
| T12 | 0.112 |
| hERG | 0.06 |
| Ames | 0.035 |
| ROA | 0.959 |
| SkinSen | 0.579 |
| Carcinogencity | 0.599 |
| EI | 0.029 |
| Respiratory | 0.563 |
| NR-Aromatase | 0.869 |
| Antiviral | Yes |
| Prediction | 0.790877 |